Healthcare Blogs and Articles
Healthcare Blogs and Articles
Healthcare Pulse
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
At the recent ASCO‑GU meeting, industry leaders highlighted that the greatest threat to emerging bladder‑cancer programs is strategic, not clinical. Phase‑2 candidates are poised to enter Phase‑3 trials, but shifting control arms, evolving endpoints, and changing patient demographics risk rendering these studies irrelevant. The report warns that without agile trial design, novel therapies may lose competitive footing before market entry. Stakeholders must anticipate regulatory and market dynamics to preserve development momentum.
Cognito Therapeutics closed an oversubscribed $105 million Series C round to fund its at‑home Alzheimer’s stimulation device, Spectris, targeting a 2027 market launch after a pivotal readout. NexCure raised $19 million in a Series A to build an outpatient platform that standardizes and expands...
Milliman’s 2025 Long‑Term Care Index estimates that a typical 65‑year‑old should earmark $135,000 for high‑intensity care, but costs diverge sharply by gender, health status and geography. Women face an average $171,000 bill versus $98,000 for men, reflecting longer lifespans. State‑level...
Aram K.’s latest post walks clinicians through the step‑by‑step process for measuring left‑ventricular ejection fraction using the Simpson’s biplane method on 2D echocardiography. It stresses acquiring both apical four‑chamber and two‑chamber views, precise endocardial tracing at end‑systole and end‑diastole, and...
The Green Party’s surprise victory in the Gorton and Denton by‑election has thrust its proposal to legalise, regulate and control all drugs into the national spotlight. Party leader Zack Polanski framed the plan as a public‑health, evidence‑based approach, while the...
Inspire Medical Systems has launched its implantable hypoglossal nerve stimulator, often called an OSA pacemaker, in the United Kingdom. The device offers a mask‑free alternative for moderate‑to‑severe obstructive sleep apnoea patients who cannot tolerate CPAP, delivering breath‑synchronised nerve stimulation to...
UC San Diego Health performed the world’s first fully personalized anterior cervical spine implant, combining high‑resolution imaging, AI‑driven design, and titanium 3D printing. The AI algorithm generated a patient‑specific geometry that matches the vertebral endplates, restores natural lordosis, and optimizes...
Late 2025 saw the FDA grant traditional approval to pirtobrutinib, an oral, reversible BTK inhibitor targeting multiple B‑cell malignancies. The drug demonstrated robust efficacy in BTK‑resistant chronic lymphocytic leukemia and small lymphocytic lymphoma, backed by positive Phase 3 data and early...
University of Waterloo researchers have engineered the anaerobic bacterium Clostridium sporogenes to consume solid tumors from the inside out. The spores infiltrate the oxygen‑free tumor core, proliferate and break down cancerous tissue. By inserting an oxygen‑resistant gene and a quorum‑sensing...
Xtalks has spotlighted Giorgia Palano, PhD, a Life Science Consultant at Knightec Group, highlighting her expertise in validation strategies and regulatory compliance. Palano works with cross‑functional teams to ensure quality documentation and continuous improvement across complex life‑science operations. She emphasizes...
The pharmaceutical industry is grappling with evolving Most‑Favored‑Nation (MFN) pricing rules as the TrumpRx initiative clarifies administration expectations. Recent Supreme Court rulings on IEEPA tariffs, distinct from Section 232 tariffs used in MFN negotiations, add uncertainty to pricing strategies. Manufacturers must...
Endometriosis UK reports the average diagnosis time in Britain has risen to nine years and four months, up from eight years in 2020. The survey shows 39% of women needed ten or more GP visits before suspicion, while 55% presented...
Researchers at WEHI and the Burnet Institute have mapped the human immune response to Plasmodium vivax, revealing how antibodies neutralize the parasite. The study, published in Immunity, shows that protective immunity depends on antibody function and simultaneous targeting of multiple...
Mosaic Clinical Technologies announced that its AI unit Cognita received FDA Breakthrough Device Designation for Cognita Chest X‑Ray (CXR), the first generative vision‑language model in radiology to earn this status. The designation grants prioritized FDA interaction, potentially accelerating clearance. Internal...
GAIA and Daiichi Sankyo Europe announced an exclusive partnership to commercialize lipodia, a digital therapeutic for hypercholesterolemia, pending regulatory approval. The agreement gives Daiichi Sankyo exclusive rights in Germany with plans to expand across Europe, leveraging GAIA’s evidence‑based platform and Daiichi’s cardiovascular...
Samoco, a smart medical transport device firm, has begun prototyping its flagship blood‑preservation system in the PHTA Makerspace. The device actively cools and agitates blood during road or drone transport, aiming to keep units viable in hot, remote environments. Up...
The author will host a LinkedIn Live demo on March 10 to showcase the Lean Hospitals Coach, an AI‑powered tool built around the *Lean Hospitals* book. The coach offers two query modes—Book Search with citations and Book Plus with broader Lean insights—and...
Tandem Diabetes Care announced that its Tandem Mobi insulin pump is now compatible with Android smartphones in the United States via a newly released mobile app. The Android version received FDA clearance in November 2025 and entered a limited rollout in...
The article debunks long‑standing myths about menopausal hormone therapy (MHT) by highlighting how the 2002 Women’s Health Initiative (WHI) trial was misapplied to all women. It explains that the WHI tested an older cohort using a specific estrogen‑progestin combo, leading...
![Rest Is a Holy Practice: Reclaiming the Soul of Medicine [PODCAST]](/cdn-cgi/image/width=1200,quality=75,format=auto,fit=cover/https://kevinmd.com/wp-content/uploads/Design-1-1-scaled.jpg)
Dr. Roxanne Almas, a developmental‑behavioral pediatrician, discusses how chronic burnout stems from medicine’s nonstop, transactional culture and shares her personal journey through grief and caregiving. She advocates for deep rest practices—such as Yoga Nidra, narrative medicine, and mindful pauses—to restore empathy,...
Health systems are drowning in operational blind spots, especially in financial operations, while existing software focuses on clinical documentation. The essay maps a high‑value opportunity stack—from payer‑contract intelligence and AP automation to workforce forecasting, OR utilization, and prior‑authorization automation—highlighting quantifiable...
During her March 2026 Senate confirmation, Dr. Casey Means faced intense questioning on vaccine policy, her professional credentials, and potential conflicts of interest. FactCheck.org examined the back‑and‑forth, verifying that her statements on vaccine safety aligned with CDC data and that...
Eton Pharmaceuticals has in‑licensed the U.S. commercialization rights to Hemangeol®, the sole FDA‑approved oral propranolol solution for infantile hemangioma, marking its tenth rare‑disease product. The hand‑off from Pierre Fabre is slated for May 1 2026, after which Eton will drive sales through its...
Democratic lieutenant‑governor candidate David Pepper condemned Republican gubernatorial frontrunner Vivek Ramaswamy’s claim that Medicare and Medicaid are "mistakes" during a Youngstown news conference. Pepper highlighted that over 2.5 million Ohioans depend on Medicare and more than 3 million on Medicaid, arguing that...
ARPA‑H is committing up to $144 million to healthspan‑focused human trials through its PROSPR program, funding seven teams to develop early biomarkers and surrogate endpoints for aging interventions. The agency has awarded Cambrian Bio $30.8 million for an oral rapamycin analog targeting...
Genelux Corporation’s President and CEO Thomas Zindrick discussed the company’s oncolytic virotherapy programs targeting ovarian cancer and non‑small cell lung cancer on the Xtalks Life Science Podcast. The interview highlighted the therapeutic potential of engineered viruses to stimulate anti‑tumor immunity...
The United States is confronting a health‑care affordability crisis, with one‑third of citizens postponing care and 41 percent burdened by medical debt. Federal spending reached $5.3 trillion in 2024—about 18 % of GDP—and is projected to climb to $8.6 trillion by 2033. Public polls...
The FDA is reportedly reconsidering its stance on peptide compounds, a shift potentially driven by officials linked to Robert F. Kennedy Jr., which could broaden research and bio‑hacking applications. Meanwhile, ivermectin has re‑entered public discourse after high‑profile media mentions, prompting...
Board‑certified emergency physician Vikas Patel proposes the evolutionary mismatch framework to rebuild patient trust. He argues that modern chronic diseases stem from a gap between ancient human biology and today’s lifestyle, not from a broken body. By reframing illness as...
Magentus announced the creation of a UK Advisory Board composed of senior NHS figures such as Dame Barbara Hakin and Professors Ian Abbs and Erika Denton. The board will provide independent insight to shape product direction, align with NHS priorities...
The article argues that professional environments mistakenly equate contribution, credentials, and service with safety, exposing a systemic failure that spans health care, academia, law enforcement and corporate sectors. It uses the tragic case of Alex Pretti to illustrate how conditional...
A federal research team found that AI diagnostic tools are being applied to patients they were never designed for, often scoring cases before a doctor even enters the room. The study labeled the resulting errors as “catastrophic,” especially for patients...
On November 20, 2020, Verb and Johnson & Johnson unveiled OTTAVA, a six‑armed robotic platform designed for minimally invasive procedures. The system combines advanced haptic feedback with AI‑driven motion planning to enhance surgeon precision. Early trials suggest OTTADA can reduce operative time...
In 2025, Europe’s EMA, China’s NMPA, and Japan’s PMDA each granted first‑time approvals for novel large‑molecule therapeutics. Oncology accounted for the largest share of these approvals, while endocrinology—driven largely by GLP‑1‑based agents—was the second biggest category. The approvals span a...
VitalHub UK and CEMBooks have formed a partnership to deliver complementary digital tools for NHS operational insight and situational awareness. The collaboration combines VitalHub’s SHREWD system‑level platform with CEMBooks’ department‑focused management suite, allowing structured local capture alongside system‑wide oversight. Both...
In a candid ER column, Dr. George Issa describes the “Blanket Sign”—the tendency of adult patients who bring personal blankets to exhibit psychiatric or drug‑seeking behavior. He recounts a 42‑year‑old woman with chronic abdominal pain, opioid history, and a barrage...
The FDA issued its first botanical drug guidance in 2004 and updated it in 2016, yet only four complex plant‑derived drugs have been approved to date. Ajna Biosciences, led by Joel Stanley, has secured clearance to begin a Phase 2 trial...
Vocxi Health has teamed with Forj Medical to shrink its MyBreathPrint breath‑analysis system from a tabletop prototype to a handheld device the size of a deck of cards. The platform leverages graphene‑based nano sensors and AI‑driven algorithms to detect disease‑linked...
Harrison.ai announced that four AI companies—AIRAmed, Koios Medical, Lunit and Nanox AI—are joining its Open Platform, expanding the catalog of imaging solutions across X‑ray, CT, MRI, mammography and ultrasound. The platform maintains a vendor‑neutral, zero‑mark‑up model, allowing healthcare organizations to...
Sequana Medical reported that five leading U.S. hospitals have implanted its alfapump System since its Q4 2025 launch, including Mount Sinai, University of Pennsylvania, Dartmouth Hitchcock, and University Medical Center of Southern Nevada. The company is actively pursuing approvals to expand...
Healthcare providers have poured resources into unified communications platforms such as Microsoft Teams, yet the majority of frontline clinicians remain underserved by devices that cannot survive rigorous hygiene protocols or unreliable wireless coverage. While administrative staff benefit from modern UC...
Brook.ai, led by CEO Oren Nissim, is scaling its remote patient monitoring (RPM) platform to cut hospital readmissions and improve care plan adherence. The company reports over 50% of its hypertension cohort achieving control within ten weeks and a roughly...
The Independent Medical Alliance (IMA) returned to Washington, D.C. in early February 2026 for a series of meetings with senators, congressional staff, HHS officials and national media. Representing more than 12,000 clinicians across 35 specialties, IMA presented frontline clinical data...
Following strong interest in the ASH25 hematologic malignancy intelligence report, Biotech Strategy Blog released a new strategic intelligence series covering the ASCO GU meeting data on prostate, bladder, and renal cell cancers. The first installment focuses on advanced prostate cancer,...
The article challenges the notion that Direct Primary Care (DPC) can thrive solely on individual consumer subscriptions, arguing that household‑income constraints limit universal demand. It highlights Bureau of Labor Statistics data showing modest health‑care spending capacity, especially for middle‑income families...
The FDA granted priority review to Takeda’s rusfertide, a first‑in‑class hepcidin mimetic for polycythemia vera, after Phase III trials more than doubled response rates. A regulatory decision is expected in Q3 2026. The agency also expanded Novo Nordisk’s once‑weekly Sogroya to treat children...
The Medical Technology Group’s new report reveals that 42 Integrated Care Boards (ICBs) lack basic data on gynaecology pathways, waiting times, diagnoses and outcomes. More than 750,000 women are currently waiting for hospital gynaecology services, yet most ICBs do not...
UK independent provider Ascenti Physio has launched its Ascenti Reach digital physiotherapy app in a six‑month pilot with York and Scarborough Teaching Hospitals NHS Foundation Trust. Early data from other users show wait times can be cut by up to...
Edinburgh‑based MyWay Digital Health has raised £3 million from Foresight Group to scale its clinically validated MyWay Diabetes platform, already deployed across several NHS regions. The funding will accelerate growth, broaden the product suite and fund AI‑enabled predictive analytics and personalized...
The American Medical Association’s Journal of Ethics published its final issue in December 2025, ending a 26‑year legacy of scholarly oversight. Simultaneously, the AMA launched a Center for Digital Health and Artificial Intelligence, signaling a strategic pivot toward technology. The...
